Cancers of the Head & Neck | Home
Cancers of the Head & Neck
Featured Article: Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease
The treatment options for patients with head and neck squamous cell carcinoma with N3 nodal disease (N3 HNSCC) are controversial due to the limited inclusion of N3 HNSCC patient populations in randomized controlled trials. It is therefore difficult to determine optimal treatment regimens for such cancers; furthermore it has been demonstrated that institutional patterns of care can influence the clinical management of N3 HNSCC.
In this research article, M. Witek et al., retrospectively analyze different treatment approaches to evaluate the long-term outcomes of patients with N3 HNSCC.
Click
here to access the full article.
Articles
Authors:Matthew E. Witek, Aaron M. Wieland, Shuai Chen, Tabassum A. Kennedy, Craig R. Hullett, Evan Liang, Gregory K. Hartig, Randy J. Kimple and Paul M. Harari
Authors:Shunji Takahashi, Naomi Kiyota and Makoto Tahara
Authors:Nnamdi Eze, Ying-Chun Lo and Barbara Burtness
Authors:David W. Schoppy, Michael E. Kupferman, Amy C. Hessel, Diana M. Bell, Elizabeth M. Garland, Edward J. Damrose and F. Christopher Holsinger
Authors:Joel Yarney, Naa A. Aryeetey, Alice Mensah, Emmanuel D. Kitcher, Verna Vanderpuye, Charles Aidoo and Kenneth Baidoo
.png)
No hay comentarios:
Publicar un comentario